PubMed Health⌕ Search

Biomedical subjects

P M Fioretti

Publications and source records attributed to P M Fioretti.

At least 73 records · Page 4Linked to original sources

Metabolic imaging using F18-fluorodeoxyglucose to assess myocardial viability.

Over the past 10 years, F18-fluorodeoxyglucose (FDG) imaging with positron emission tomography (PET) has emerged as an important technique in the delineation of myocardial viability. Using this technique it has become possible to predict recovery of ventricular function after revascularization in patients with chronic coronary artery disease. Data from long-term (although retrospective) follow-up studies have demonstrated that patients with viable myocardium on FDG PET who do not undergo revascularization are prone to cardiac events, including cardiac death and non-fatal infarction. The same studies have pointed out that patients with viable tissue on FDG PET, who do undergo revascularization, improve substantially in symptoms related to congestive heart failure. To allow FDG imaging in centers without PET equipment, recent studies have evaluated the use of FDG imaging with single photon emission computed tomography (SPECT) and 511 keV collimators. Preliminary data using this alternative approach are promising, but need further confirmation. In this review the experience with FDG imaging (using either PET or SPECT) in the assessment of tissue viability in patients with coronary artery disease will be discussed.

Coronary Disease↗

FDG SPECT in the assessment of myocardial viability. Comparison with dobutamine echo.

The use of 18F-fluorodeoxyglucose (FDG) imaging with single photon emission computed tomography (SPECT) has been introduced recently to assess myocardial viability. Several centres have now gained experience with cardiac FDG SPECT imaging, and this report is a summary of the currently available FDG SPECT data. Three studies have compared FDG SPECT with FDG positron emission tomography and demonstrated good agreement between them. Initial results in patients undergoing revascularization suggest that FDG SPECT can predict improvement in contractile function after revascularization. Although the initial results are promising, larger studies are needed to determine the precise role of FDG SPECT in the assessment of myocardial viability.

Cardiotonic Agents↗

Should the diagnosis of coronary artery disease be based on the evaluation of myocardial function or perfusion?

The aim of this review was to define the place of stress (exercise, dobutamine, and vasodilator) echocardiography in the context of perfusion scintigraphic techniques for the detection of coronary artery disease. Echocardiography and nuclear imaging have their strong and weak points. Echocardiography has the benefit of widespread availability, relatively low cost, portability, absence of radiation, safety, and determination of ischaemic threshold. However, echocardiographic imaging cannot be performed during treadmill exercise, the echocardiographic windows are variable with sometimes poor echogenicity, and interpretation is subjective and requires an important learning curve. Diagnostic comparisons were focused on studies involving echocardiographic and nuclear imaging in the same patients. These direct comparisons show that exercise or dobutamine echocardiography and perfusion imaging have similar accuracies for the detection and localization of coronary artery disease. Perfusion imaging may be more sensitive in the detection of mild coronary artery disease; echocardiography, however, has a better specificity. Vasodilator perfusion imaging is superior to vasodilator echocardiography, although the new dipyridamole-atropine echocardiography test will make future reassessment necessary. Once the condition of adequate echocardiographic training is fulfilled, we believe that the selection of one or other test should be tailored to clinical circumstances rather than be a uniform decision.

Cardiotonic Agents↗

Prognostic value of dobutamine-atropine stress echocardiography for peri-operative and late cardiac events in patients scheduled for vascular surgery.

Cardiac events in the peri-operative phase and late after non-cardiac vascular surgery are a major cause of morbidity and mortality. Numerous tests and diagnostic strategies--usually consisting of a combination of analysis of clinical risk factors and additional non-exercise dependent stress testing, such as thallium scintigraphy, or stress echocardiography--have been developed to preoperatively identify patients with increased risk. The tests ideally should identify three subpopulations in a group with a high prevalence of coronary artery disease; (1) low-risk patients who can be referred for surgery without extra cardiac intervention. (2) patients whose peri-operative cardiac risk outweighs the potential benefits of vascular surgery, (3) patients whose risk may be reduced by peri-operative therapeutic interventions. This review will discuss the prognostic value of dobutamine stress echocardiography for risk stratification in patients scheduled for non-cardiac vascular surgery and discuss guidelines for future management.

Atropine↗

Cardiac magnetic resonance imaging findings in patients with right ventricular outflow tract premature contractions.

AIMS: To assess prospectively the value of cardiac magnetic resonance imaging in patients with apparently idiopathic premature contractions arising from the right ventricular outflow tract. METHODS: We compared magnetic resonance imaging scans in 19 patients (13 males and six females, mean age 44 years) with frequent (> 100 per hour), monomorphic (left bundle branch block and inferior axis morphology) extrasystoles, and in 10 volunteers (four males and six females, mean age 36.7 years) without structural heart disease. Magnetic resonance imaging studies (1 or 1.5 Tesla) included spin-echo and gradient-echo sequences in the standard planes. The presence of structural and dynamic abnormalities of the right and left ventricles, such as reduced wall thickness, systolic bulging, and decreased systolic thickening, were evaluated. In addition, end-diastolic diameters of the right ventricular outflow tract were measured in the transverse plane. RESULTS: The dimensions of the right ventricular outflow tract were wider in patients with extrasystoles compared to the control group. Mean anteroposterior and transverse diameters were 39.6 +/- 4.6 mm vs 29.9 +/- 4.8 mm (P < 0.01) and 27.5 +/- 3.8 mm vs 20.5 +/- 2.5 mm (P < 0.01), respectively. Wall motion and morphological abnormalities were present in 16/19 (84%) patients, and were confined to the anterolateral wall in 15/16 cases. All normal subjects had normal magnetic resonance imaging findings (P = 0.008). CONCLUSIONS: Cardiac magnetic resonance imaging revealed that in patients with idiopathic right ventricular outflow tract premature contractions there was a higher rate of morphological and functional abnormalities of the right ventricular outflow tract than in the normal subjects. Large studies and long follow-up are needed to confirm whether these findings could help identify a localized form of arrhythmogenic cardiomyopathy, and its clinical significance.

Adolescent↗

Prediction of improvement of ventricular function after revascularization. 18F-fluorodeoxyglucose single-photon emission computed tomography vs low-dose dobutamine echocardiography.

AIMS: To compare assessment of myocardial flow and glucose metabolism by single-photon emission computed tomography (SPECT) with low-dose dobutamine echocardiography in predicting improvement in regional and global left ventricular function after coronary artery bypass grafting. METHODS AND RESULTS: Thirty patients with regional wall motion abnormalities (mean ejection fraction 32 +/- 19%) were studied with low-dose dobutamine echocardiography (5 and 10 micrograms. kg-1 min-1) and thallium-201/ 18F-fluorodeoxyglucose(FDG) SPECT prior to surgery. For comparative analysis, a 13-segment model was used. Postoperative improvement was predicted if the echocardiogram showed that wall motion abnormalities were reversible during the dobutamine infusion and there was normal perfusion or relatively increased FDG uptake in perfusion defects (mismatch) in dyssynergic segments on SPECT. After surgery, ventricular function was reassessed. An echocardiogram was taken at the 3 month follow-up with the patient at rest. Regional wall motion had improved in 62/168 (37%) revascularized segments. In predicting functional outcome, low-dose dobutamine echocardiography reached a sensitivity of 89% and a specificity of 82%, with a positive predictive value of 74% and a negative predictive value of 93%, whereas for thallium-201/FDG SPECT these values were 84%, 86%, 78% and 90%, respectively. In patients with more than two viable segments on either technique, the wall motion score index, a surrogate of global ventricular function, improved significantly. CONCLUSION: For the optimal prediction of functional outcome, combined assessment of flow and FDG imaging is needed. Both thallium-201/FDG SPECT and low-dose dobutamine echocardiography appear comparable and similarly accurate in predicting improvement of left ventricular function after surgical revascularization.

Analysis of Variance↗

The apical long-axis rather than the two-chamber view should be used in combination with the four-chamber view for accurate assessment of left ventricular volumes and function.

BACKGROUND: Most biplane methods for the echocardiographic calculation of left ventricular volumes assume orthogonality between paired views from the apical window. Our aim was to study the accuracy of biplane left ventricular volume calculations when either the apical two-chamber or long-axis views are combined with the four-chamber view. The left ventricular volumes calculated from three-dimensional echocardiographic data sets were used as a reference. Twenty-seven patients underwent precordial three-dimensional echocardiography using rotational acquisition of planes at 2-degree intervals, with ECG and respiratory gating. End-diastolic and end-systolic left ventricular volumes and ejection fraction on three-dimensional echocardiography were calculated by (1) Simpson's methods (3DS) at 3 mm short-axis slice thickness (reference method) and by (2) biplane ellipse from paired views using either apical four- and two-chamber views (BE-A) or apical four- and long-axis views (BE-B). Observer variabilities were studied by the standard error of the estimate % (SEE) in 19 patients for all methods. RESULTS: The spatial angles (mean +/- SD) between the apical two-chamber, long-axis and four-chamber views were 63.3 degrees +/- 19.7 and 99.1 degrees +/- 25.6, respectively. The mean +/- SD of end-diastolic and end-systolic left ventricular volumes (ml) and ejection fraction (%) by 3DS were 142.2 +/- 60.9, 91.8 +/- 59.6 and 39.6 +/- 17.5, while that by BE-A were 126.7 +/- 60.4, 84.0 +/- 57.9 and 39 +/- 17 and by BE-B were 134.3 +/- 62.4, 88.6 +/- 59.7 and 39.1 +/- 16.7, respectively. BE-B intra-observer (8.4, 6.7 and 3.5) and inter-observer (9.8, 11.5 and 5.4) SEE for end-diastolic and end-systolic left ventricular volumes (ml) and ejection fraction (%), respectively, were smaller than that for BE-A (10.8, 8.8 and 4.1 and 11.4, 14.7 and 6.1, respectively). There was excellent correlation between 3DS and BE-A (r = 0.99, 0.98 and 0.98) and BE-B (0.98, 0.98 and 0.98) for calculating end-diastolic and end-systolic left ventricular volume and ejection fractions, respectively. There were no significant differences between BE-A and BE-B with 3DS for end-diastolic and end-systolic left ventricular volume and ejection fraction calculations (P = 0.2, 0.3 and 0.4 and P = 0.5, 0.5 and 0.4, respectively). There were closer limits of agreement (mean +/- 2 SD) between 3DS and BE-B 7.9 +/- 18.8, 3.2 +/- 14.2 and 0.8 +/- 5.8 than that between 3DS and BE-A 15.5 +/- 19.6, 7.8 +/- 16.2 and 1.1 +/- 7.4 for calculating end-diastolic and end-systolic left ventricular volume and ejection fractions, respectively. CONCLUSION: Both apical two-chamber and apical long-axis views are not orthogonal to the apical four-chamber view. Observer variabilities of BE-B were smaller than that for BE-A. BE-A and BE-B have excellent correlation and non-significant differences with 3DS for left ventricular volume and ejection fraction calculations. There were closer limits of agreement between BE-B with 3DS for left ventricular volume and ejection fraction calculations than that between BE-A and 3DS. Therefore, we recommend the use of the apical long-axis rather than the two-chamber view in combination with the four-chamber view for accurate biplane left ventricular volume and ejection fraction calculations.

Adult↗

Hemodynamic changes, plasma catecholamine responses, and echocardiographically detected contractile reserve during two different dobutamine-infusion protocols.

We studied hemodynamic changes, catecholamine responses, and the occurrence of improved wall thickening by echocardiography during two different dobutamine-infusion protocols. Forty-three patients were studied by using a stepwise incremental dobutamine dose-infusion protocol (10-40 microg/kg/min, 3-min intervals); a subgroup of 11 patients also underwent a continuous dobutamine-infusion protocol (10 microg/kg/min for 12 min) in random order. No patient used beta-blockers. At 3-min intervals, blood pressure, heart rate, and plasma concentrations of dobutamine, epinephrine, and norepinephrine were measured. The echocardiographic improvement of wall thickening was analyzed only in paired protocols by visual assessment in left ventricular regions with normal wall motion at rest. The mean heart rate increased in the continuous and stepwise protocols from 73 to 99 and 74 to 132 beats/min. There was no significant change in blood pressure response between the two protocols. The mean plasma dobutamine concentrations during the continuous and stepwise protocols at 0, 3, 6, 9, and 12 min were 0/0; 31/38; 80/203; 106/448; and 120/692 ng/ml, respectively. In each patient, a response curve was constructed for the plasma dobutamine concentration versus heart rate. The heart rate increment and dobutamine concentration at which wall thickening was detected were similar with both protocols (14 +/- 5 vs. 12 +/- 7 beats/min) and (80 +/- 40 vs. 92 +/- 48 ng/ml; mean +/- SD). Wall thickening was noted in two of 11 patients between 0 and 3 min and 11 of 11 patients between 3 and 6 min in both protocols. Catecholamine responses during the continuous and stepwise protocols were epinephrine, 23 versus 28/28 versus 36, and norepinephrine 301 versus 323/347 versus 519. Only norepinephrine plasma concentrations increased significantly during the stepwise protocol. A 6-min dobutamine infusion was sufficient during both protocols to reach an adequate plasma dobutamine concentration, which induced a detectable increase of wall thickening in all patients. There is a significant differences between the two protocols with regard to the plasma catecholamine changes, so some of the hemodynamic effects during the stepwise dobutamine-infusion protocol may be mediated through release of endogenous catecholamines.

Adrenergic beta-Agonists↗

Dobutamine 99Tcm-MIBI SPET myocardial perfusion scintigraphy in the prediction of restenosis after percutaneous transluminal coronary angioplasty in patients unable to perform an exercise stress test.

After successful percutaneous transluminal coronary angioplasty (PTCA), restenosis occurs in a relatively high proportion of patients. Exercise thallium scintigraphy is a useful method for the detection of restenosis. In patients unable to exercise, dobutamine perfusion scintigraphy may represent a feasible alternative. However, its diagnostic accuracy in this clinical setting has not been evaluated. We studied 40 patients (29 males, 11 females) aged 57 +/- 9 years, at a mean of 185 +/- 80 days after successful PTCA with a high-dose dobutamine (up to 40 micrograms kg-1 min-1) stress test, in conjunction with 99Tcm-methoxyisobutyl isonitrile (99Tcm-MIBI) single photon emission tomography (SPET). Significant restenosis was defined as > or = 50% luminal diameter stenosis of a coronary segment with previous PTCA and was predicted on the basis of the occurrence of reversible perfusion defects in the corresponding territories. Reversible perfusion defects occurred in 20 of 29 arteries with and in 4 of 17 arteries without restenosis. The sensitivity of dobutamine MIBI for the detection of restenosis in arteries with previous PTCA was 69% (CI = 56-82), the specificity 76% (CI = 64-89), the positive predictive value 83% (CI = 73-94), the negative predictive value 59% (CI = 45-73) and accuracy 72% (CI = 59-85). The overall sensitivity of 99Tcm-MIBI SPET for the diagnosis of significant coronary stenosis (including arteries without previous PTCA) on a patient basis was 79% (CI = 67-92), the specificity 82% (CI = 70-94) and accuracy 80% (CI = 68-92). The sensitivity of 99Tcm-MIBI SPET was significantly higher than that of electrocardiography (79 vs 38%, P < 0.005). It is concluded that dobutamine 99Tcm-MIBI SPET is a useful method for the detection of restenosis after PTCA in patients unable to perform an exercise stress test.

Adult↗

Relation between ST segment elevation during dobutamine stress test and myocardial viability after a recent myocardial infarction.

OBJECTIVE: To assess the relation between ST segment elevation during the dobutamine stress test and late improvement of function after acute Q wave myocardial infarction. PATIENTS AND DESIGN: 70 patients were studied a mean (SD) 8 (3) days after acute myocardial infarction with high dose dobutamine-atropine stress echocardiography and a follow up echocardiogram at 85 (10) days. A score model based on 16 segments and four grades was used to assess left ventricular function. Functional improvement was defined as a reduction of wall motion score > or = 1 in > or = 1 segments at follow up. INTERVENTION: Myocardial revascularisation was performed in 23 patients (33%) before follow up studies. RESULTS: ST segment elevation occurred in 40 patients (57%). Late functional improvement occurred in 35 patients (50%). Functional improvement was more common in patients with ST segment elevation (68% v 30%, P < 0.005) and they had a higher mean (SD) number of improved segments at follow up (1.9 (2.2) v 0.5 (1.1), P < 0.005). The wall motion score index decreased between baseline and follow up in patients with ST segment elevation (1.54 (0.50) v 1.48 (0.43), P < 0.05) but not in patients without ST segment elevation (1.39 (0.60) v 1.45 (0.47)). The accuracy of ST segment elevation for the prediction of functional improvement was similar to that of low dose dobutamine echocardiography in patients with anterior infarction (80% v 83%) and in patients who underwent revascularisation (78% v 83% respectively). CONCLUSION: In patients with a recent Q wave myocardial infarction, dobutamine-induced ST segment elevation is a valuable marker of myocardial viability particularly when the test is performed without or with suboptimal echocardiographic imaging.

Cardiotonic Agents↗

Safety and feasibility of dobutamine-atropine stress testing in hypertensive patients.

Dobutamine stress testing is increasingly used for the diagnosis and functional evaluation of coronary artery disease. The aim of this study was to assess the hemodynamic profile, safety, and feasibility of dobutamine stress testing in hypertensive patients. Dobutamine (up to 40 micrograms/kg per minute)-atropine (up to 1 mg) stress echocardiography was performed for the detection of myocardial ischemia in 1164 patients with limited exercise capacity (age, 60 +/- 12 years; 761 men); 446 patients were known to have hypertension. The test was considered feasible when 85% of the maximal heart rate and/or an ischemic end point (new or worsened wall motion abnormalities, ST segment depression, or angina) was achieved. No myocardial infarction or death occurred during the test. Dobutamine induced a significant increase of heart rate in patients with and without hypertension (59 +/- 25 and 63 +/- 23 beats per minute, respectively). Peak rate pressure product was similar in patients with and without hypertension (18,566 +/- 4584 and 18,230 +/- 4508). Hypotension (systolic pressure drop > 40 mm Hg) during the test was more frequent in hypertensive patients (7% versus 4% in normotensive, P < .05). Independent predictors of hypotension were baseline systolic pressure greater than 140 mm Hg (odds ratio, 6.9; 95% confidence interval, 3.4 to 14), older age (odds ratio, 1.04; 95% confidence interval, 1.01 to 1.07), and medication with calcium channel blockers (odds ratio, 1.8; 95% confidence interval, 1.1 to 3.5). The prevalence of ventricular tachycardia was similar (4.1%) in both groups. Episodes of 10 beats or more (0.06% of patients) were terminated promptly by intravenous metoprolol administration. Dobutamine stress testing was considered feasible in 91% of patients with and 92% of patients without hypertension. Dobutamine-atropine stress echocardiography is a safe and feasible method for the assessment of hypertensive patients referred for evaluation of myocardial ischemia. Despite the higher prevalence of dobutamine-induced hypotension in these patients, the feasibility of the test is comparable to that in individuals without hypertension.

Aged↗

Doppler tissue imaging in the new era of digital echocardiography.

Doppler tissue imaging is one of the most recent technical achievements of clinical echocardiography. Different Doppler modes are encompassed by Doppler tissue imaging: tissues velocity, pulsed wave-doppler, acceleration, phase, synchronicity and energy modes. With the exception of the energy mode, all modes are based on the Doppler shift, according to the strength of the Doppler signals from the tissues. The most widely used mode is tissue velocity, in which the velocity of moving tissue is calculated in relation to the transducer from the Doppler shift and is displayed as colour-encoded velocity maps in M-mode and two-dimensional imaging formats. Both curved M-mode, applied on two-dimensional images, and three-dimensional reconstruction appear among the most promising applications of velocity mode for the quantitative assessment of regional left ventricular function. A second Doppler mode, pulsed wave-doppler tissue imaging, displays the velocity profile of a region of interest versus time. The velocity data are displayed with a high temporal resolution, but with the disadvantage of a low spatial resolution. A third Doppler mode, tissue acceleration, displays the differences in velocity between subsequent frames in colour-encoded maps. A clinical application has been found in the electrophysiologic field. Other Doppler modes, phase and synchronicity, still require clinical assessment. Lastly, the tissue energy or power mode displays the strength of the Doppler signal from the tissues as gradations of the colour intensity in colour-encoded maps. One of its fields of application appears to be the study of myocardial perfusion with contrast agents. The development of new dedicated algorithms for colour quantification, along with the beginning of the new era of digital echocardiography, should help bring Doppler tissue imaging into the clinical arena.

Echocardiography, Doppler, Color↗

Detection of myocardial viability with F-18-fluorodeoxyglucose and single photon emission computed tomography.

The application of 18-F-fluorodeoxyglucose (FDG) imaging with single photon emission computed tomography (SPECT) to detect tissue viability has been introduced recently in several centers, both in Europe and the USA. This paper summarizes the available data on FDG SPECT. Three studies have performed a direct comparison between FDG SPECT and FDG PET, showing good agreement between these techniques. Preliminary data in patients with poor left ventricular function undergoing revascularization suggest that FDG SPECT can predict improvement of ventricular function after revascularization. Comparative studies between FDG SPECT and low-dose dobutamine echocardiography also showed close agreement. Although the initial results are promising, larger studies are needed to determine the precise role of FDG SPECT in the assessment of myocardial viability.

Cardiotonic Agents↗

Accurate measurement of left ventricular ejection fraction by three-dimensional echocardiography. A comparison with radionuclide angiography.

BACKGROUND: Three-dimensional echocardiography is a promising technique for calculation of left ventricular ejection fraction, because it allows its measurement without geometric assumptions. However, few data exist that study its reproducibility and accuracy in patients. METHODS AND RESULTS: Twenty-five patients underwent radionuclide angiography and three-dimensional echocardiography that used the rotational technique (2 degrees interval and ECG and respiratory gating). Left ventricular volume and ejection fraction were calculated by use of Simpson's rule at a slice thickness of 3 mm. Analyses were performed to define the largest slice thickness required for accurate calculation of left ventricular volume and ejection fraction. Three-dimensional echocardiography showed excellent correlation with radionuclide angiography for calculation of left ventricular ejection fraction (mean +/- SD, 38.9 +/- 19.8 and 38.5 +/- 18.0, respectively; r = .99); their mean difference was not significant (0.03 +/- 0.17; P = .3), and they had a close limit of agreement (-0.385, 0.315). Intraobserver variability for radionuclide angiography and three-dimensional echocardiography was 4.2% and 2.6%, respectively, whereas interobserver variability was 6.2% and 5.3%, respectively. There was no significant difference between left ventricular volume and ejection fraction calculated at a slice thickness of 3 mm and that calculated at different slice thicknesses up to 24 mm. However, the standard deviation of the mean difference showed a stepwise increase, particularly at thicknesses > 15 mm. At a slice thickness of 15 mm, the probability of three-dimensional echocardiography to detect > or = 6% difference in ejection fraction was 80%. CONCLUSIONS: Three-dimensional echocardiography has excellent correlation with radionuclide angiography for calculation of left ventricular ejection fraction in patients and has an observer variability similar to that of radionuclide angiography. We recommend the use of a 15-mm-thick slice for accurate and rapid measurement of left ventricular volume and ejection fraction.

Adult↗

Prognostic significance of normal dobutamine-atropine stress sestamibi scintigraphy in women with chest pain.

To evaluate the prognostic value of normal dobutamine-atropine technetium-99m sestamibi single-photon emission computed tomography (SPECT) perfusion imaging in women with chest pain and inability to perform an adequate exercise test, 80 women with a normal scintigram were followed up for 23 +/- 13 months. Mean age of the patients was 61 +/- 12 years. Nine patients (11%) had a low probability (< 10%) of coronary artery disease, 43 (54%) had an intermediate probability (10% to 80%) of disease, and 28 (35%) had a high probability (>80%) of disease (including 19 patients with known coronary artery disease). During follow-up, no major cardiac events (cardiac death or nonfatal myocardial infarction) occurred. One patient with known coronary disease underwent coronary bypass surgery after 3 months, and 1 patient with a 91% pretest likelihood of coronary disease underwent coronary angioplasty after 7 months. Thus, the overall incidence of (soft) cardiac events during the follow-up period was 2 of 80 patients, or 1.3%/year. It is concluded that normal dobutamine-atropine technetium-99m sestamibi SPECT perfusion imaging in women with chest pain implies an excellent prognosis, even in women with high pretest likelihood of coronary disease.

Adult↗

Relation between contractile response of akinetic segments during dobutamine stress echocardiography and myocardial ischemia assessed by simultaneous thallium-201 single-photon emission computed tomography.

There are no standard criteria for the diagnosis of myocardial ischemia in akinetic segments during dobutamine stress echocardiography (DSE). The aim of the study was to assess the relation between different responses of akinetic segments during DSE and ischemia assessed by thallium-201 single-photon emission computed tomography (SPECT). Dobutamine-atropine stress echocardiography with simultaneous stress-reinjection thallium-201 SPECT was performed in 67 patients with old myocardial infarction significant and coronary artery stenosis. Fourteen myocardial segments were matched for both DSE and SPECT. Ischemia on SPECT was defined as reversible thallium defects. In 257 akinetic segments, 4 patterns during DSE were identified: (1) biphasic response in 41 segments (16%), defined as improvement at low dose (5 to 10 microgram/kg/min) followed by worsening at high dose; (2) persistent akinesia in 155 segments (60%); (3) akinesia becoming dyskinesia in 39 segments (15%); and (4) sustained improvement in 22 segments (9%). Reversible thallium defects were detected in 21 segments (51%) in group 1, in 20 segments (13%) in group 2, none in group 3, and in 2 segments in group 4 (9%). The prevalence of reversible defects in biphasic segments was higher compared with other patterns (p <0.00001 vs groups 2 and 3, p <0.005 vs group 4). The ischemic perfusion defect score was significantly higher in group 1 than group 2. The positive predictive value of biphasic response for reversible thallium defects was similar to that of stress-induced dyssynergia in normal segments at rest (51% vs 58%). It is concluded that of the various responses of akinetic segments to dobutamine infusion, the biphasic response is associated with the highest prevalence and greatest severity of ischemic on thallium SPECT. Observation of contractile response at both low- and high-dose DSE is a valuable approach for the diagnosis of myocardial ischemia in akinetic segments.

Aged↗